The million dollar drug that patients can't access

Name: The million dollar drug that patients can't access
Uploaded: 2018-11-14T03:02:22.000Z
Duration: 678 s
Description: Glybera is a made-in-Canada discovery that made history, becoming the world's first drug approved to treat a genetic disease. But when it went on the market at a price of $1 million, it was immediately labelled the most expensive drug in the world and was only sold once.

6 years ago
News
Duration 11:18

Glybera is a made-in-Canada discovery that made history, becoming the world's first drug approved to treat a genetic disease. But when it went on the market at a price of $1 million, it was immediately labelled the most expensive drug in the world and was only sold once.